TransMedics (TMDX) Cash from Investing Activities Growth (1y) (2019 - 2026)
TransMedics (TMDX) Cash from Investing Activities Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -87.14% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -208.79% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -397.90% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -514.25% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -187.82% |
| 10 | TransMedics | 2.56 Bn | 2.10 Bn | 101.16 Mn | -35.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.58% |
| Dec 31, 2025 | -14.02% |
| Sep 30, 2025 | 84.04% |
| Jun 30, 2025 | 61.81% |
| Mar 31, 2025 | 38.79% |
| Dec 31, 2024 | 67.46% |
| Sep 30, 2024 | 68.12% |
| Jun 30, 2024 | -1,621.96% |
| Mar 31, 2024 | -4,665.05% |
| Dec 31, 2023 | -1,412.95% |
| Sep 30, 2023 | -705.41% |
| Jun 30, 2023 | -106.27% |
| Mar 31, 2023 | -108.82% |
| Dec 31, 2022 | -127.66% |
| Sep 30, 2022 | 299.23% |
| Jun 30, 2022 | 478.73% |
| Mar 31, 2022 | 13.40% |
| Dec 31, 2021 | 1.09% |
| Sep 30, 2021 | 126.41% |
| Jun 30, 2021 | 109.34% |